Source: Health Products Regulatory Authority (IE) Revision Year: 2022 Publisher: Novo Nordisk A/S, Novo Allé, DK-2880, Bagsværd, Denmark
Kliogest 2 mg/1 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablets. White, film-coated, biconvex tablets, engraved with NOVO 281. Diameter 6 mm. |
Each film-coated tablet contains: estradiol 2 mg (as estradiol hemihydrate) and norethisterone acetate 1 mg.
Excipient with known effect: lactose monohydrate.
Each white film-coated tablet contains lactose monohydrate 36.3 mg.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
|
Norethisterone |
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. |
List of Excipients |
---|
Tablet core: Lactose monohydrate Film-coating: White tablets: Hypromellose |
1 × 28 tablets in calendar dial packs.
The calendar dial pack with 28 tablets consists of the following 3 parts:
Novo Nordisk A/S, Novo Allé, DK-2880, Bagsværd, Denmark
PA0218/022/001
Date of first authorisation: 18 November 1987
Date of last renewal: 18 November 2007
Drug | Countries | |
---|---|---|
KLIOGEST | Austria, Germany, Estonia, Finland, France, Hong Kong, Ireland, Lithuania, Netherlands, New Zealand, Poland, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.